Breaking Darline Graham Announces Political Bid in South Carolina Tourist Plane Crashes Near Nazca, Peru; All 13 Aboard Killed Explosion Outside Colombian Police Base Injures 11 Officers, Kills Police Dog FBI Investigates Cyberattacks Targeting Water Systems in Michigan and Minnesota Michigan Supreme Court Orders Reconsideration of Enbridge Line 5 Tunnel Permit

Saturday August 1, 2026

Reporter

Johnson & Johnson

2Articles Published

5Communities Covered

Published Articles

Press Release

Johnson & Johnson’s RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) receives U.S. FDA Priority Review as potential first-in-class EGFR- and MET-targeted subcutaneous treatment for advanced head and neck cancer

Jul 30

Press Release

TECVAYLI® + TALVEY® reduced the risk of disease progression or death by 89% and the risk of death by 62% in earlier-line relapsed/refractory multiple myeloma

Jul 23